AGIO:NASDAQ
Agios Pharmaceuticals Inc
$29.89
arrow_downward
-0.86%(-0.26) 1D
$29.89
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 17, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$30.09
High
$30.38
Low
$28.94
Mkt. cap
1.79B
Avg. vol.
1.23M
Volume
1.00
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
Open
$30.09
High
$30.38
Low
$28.94
Mkt. cap
1.79B
Avg. vol.
1.23M
Volume
1.00
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
News stories
From web sources and news partners
FOREX.com
·
4 minutes ago
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
TradingView
·
2 hours ago
Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead of FOMC Minutes— NVDA, AAOI, PANW in Focus
BeInCrypto
·
1 hour ago
How Deep Do S&P 500 Corrections Usually Go? Where 2026’s Drop Ranks
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc